Fluid Therapy and Glycocalyx Shedding During Moderate Surgery

NACompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

May 13, 2020

Primary Completion Date

August 3, 2023

Study Completion Date

August 3, 2023

Conditions
Abdominoplasty
Interventions
OTHER

Lactated Ringer's Fluid Bolus Response to Low Urinary Output

During the surgical procedure and the subsequent stay in the Post-Anesthesia Care Unit: if the study participant's urine output (UO) remains \<0.3 ml/kg/h for two consecutive hours, an IV bolus of 250 ml of lactated Ringer's solution will be administered over 15 min and repeated every 30 min until the UO reaches \>0.3 ml/kg/h.

OTHER

Post-Anesthesia Care Unit Lactated Ringer's Fluid Management Protocol

During their stay in the Post-Anesthesia Care Unit, patients will receive a 1.5 ml/kg/h IV infusion of lactated Ringer's solution.

Trial Locations (1)

9112001

Hadassah Ein-Carem Medical Center, Jerusalem

All Listed Sponsors
collaborator

Hebrew University of Jerusalem

OTHER

lead

Hadassah Medical Organization

OTHER

NCT05939518 - Fluid Therapy and Glycocalyx Shedding During Moderate Surgery | Biotech Hunter | Biotech Hunter